PR

Gencurix News

Gencurix working with global companies, "approval of companion di…

페이지 정보

작성자 최고관리자 댓글 0건 조회 26회 작성일 18-05-18 11:14

본문

Molecular diagnosis health care company, GENCURIX, is speeding up its clinical trials in order to obtain approval for its " lung cancer companion diagnostic kit " that is being developed jointly with global pharmaceutical company, Astrazeneca by end of this year.

The CEO of GENCURIX, Cho Sang-rae, announced that "We are currently working with two domestic university hospitals to get approved from the Ministry of Food and Drug Safety. "at the 6th Bio Leader's Club hosted by News1 at Lotte Hotel in Seoul.

[Original Text]

댓글목록

등록된 댓글이 없습니다.